Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Cancer Therapies02:49

Cancer Therapies

7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of Surgery in the Multimodal Treatment of Pituitary Carcinoma: A Retrospective Single-Institution Case Series.

Cancers·2026
Same author

Factors Associated With Overall Survival and 90-Day Mortality Following Resection of Melanoma Brain Metastases.

Operative neurosurgery (Hagerstown, Md.)·2026
Same author

EGFR inhibition down-regulates MGMT and enhances responsiveness to temozolomide in glioblastoma.

Science translational medicine·2026
Same author

Extent of resection as an independent predictor of survival for patients with glioblastoma as defined by the new WHO 2021 classification.

Journal of neurosurgery·2026
Same author

Cystic glioblastoma is associated with alterations of KDR and the Rb pathway: a single-center retrospective analysis.

Acta neuropathologica communications·2026
Same author

Loss of pituitary hormone function after stereotactic radiosurgery for pituitary adenomas: mechanisms and management.

Journal of neuro-oncology·2026

Related Experiment Video

Updated: Jul 2, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.4K

Therapeutic Strategies for Gliomas Associated With Cancer Predisposition Syndromes.

Keng Lam1, Carlos Kamiya-Matsuoka1, John M Slopis1

  • 1Department of Neuro-Oncology, The University of Texas MD Anderson Cancer, Houston, TX.

JCO Precision Oncology
|February 23, 2024
PubMed
Summary

Syndromic gliomas, linked to cancer predisposition syndromes (CPSs), require tailored treatments. Standard therapies may pose risks, highlighting the need for novel approaches in managing these rare brain tumors.

More Related Videos

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

18.1K
Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations
04:46

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Published on: February 24, 2023

1.5K

Related Experiment Videos

Last Updated: Jul 2, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.4K
The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

18.1K
Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations
04:46

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Published on: February 24, 2023

1.5K

Area of Science:

  • Neuro-oncology
  • Genetics
  • Cancer Research

Background:

  • Cancer predisposition syndromes (CPSs) are genetic conditions increasing cancer risk.
  • Specific CPSs, including neurofibromatosis and Li-Fraumeni syndrome, are associated with glioma development.
  • Syndromic gliomas represent a distinct subset of brain tumors with unique management considerations.

Purpose of the Study:

  • To provide a comprehensive overview of syndromic gliomas.
  • To discuss the clinical characteristics and management strategies for patients with CPSs and gliomas.
  • To explore the potential role of novel therapeutic approaches in syndromic glioma treatment.

Main Methods:

  • Nonsystematic literature review.
  • Analysis of existing data on syndromic gliomas.
  • Synthesis of information on genetic predispositions and treatment modalities.

Main Results:

  • Standard glioma treatments (radiation, chemotherapy) may increase risks in patients with CPSs.
  • Targeted therapies and immunotherapies may be considered based on specific genetic aberrations.
  • Limited data currently exists on the clinical characteristics, treatment strategies, and prognosis of syndromic gliomas.

Conclusions:

  • Management of syndromic gliomas necessitates careful consideration of the underlying CPS.
  • Novel treatment strategies are crucial for improving outcomes in patients with syndromic gliomas.
  • Further research is needed to fully understand and optimize the care of individuals with syndromic gliomas.